Ensysce Biosciences, Inc. Debt Instrument, Fair Value Disclosure
Discontinued › Balance Sheet › Liabilities › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2024-03-15
- 2023-12-31: Debt Instrument, Fair Value Disclosure $1.20M.
- 2022-12-31: Debt Instrument, Fair Value Disclosure $287.77K.
- 2022-09-30: Debt Instrument, Fair Value Disclosure $24.82K.
- 2022-06-30: Debt Instrument, Fair Value Disclosure $29.20K.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2023-12-31 | $1.20M 10-K · filed 2024-03-15 |
| 2022-12-31 | $287.77K 10-K · filed 2024-03-15 |
| 2022-09-30 | $24.82K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $29.20K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $509.19K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.30M 10-Q · filed 2022-08-11 |
| 2021-09-30 | $620.72K 10-Q · filed 2021-11-15 |